In fight over Medicare payments, the hospital lobby shows its strength

In the battle to control health care costs, hospitals are deploying their political power to protect their bottom lines.

Private equity escapes FTC in court, but anesthesia group doesn’t

Welsh, Carson, Anderson & Stowe has wiggled out of the grasp of the Federal Trade Commission, but the private equity firm’s anesthesia company, U.S. Anesthesia

May 20, 2024

Seagen teams up with protein degradation specialist to make a new kind of antibody conjugate, paying $60M upfront

Seagen, whose suite of antibody-drug conjugates enticed Pfizer to a $43 billion buyout, is looking to put a twist on the idea. The Seattle-based drugmaker

September 8, 2023

Taysha teases early gene therapy data for Rett syndrome

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.